Research
.png)
CCIV has five integrative focus areas that are designed to build new collaborations, leading to sustainable research programs, new grant opportunities and important discoveries.
Basic Immunology & Assay Development Program
This program studies innate and adaptive immunity to viral and bacterial pathogens, as well as vaccine-elicited immune responses. Assays to quantify immune responses and virus persistence have been developed by the following research leaders:
HIV Research Program
CCIV covers the full spectrum of basic, translational, clinical, public health, and implementation sciences related to HIV Research. Research leaders in this area include:
- Ann Chahroudi
- Lisa Cranmer
- Maddie Goldstein
- Cassie Grimsley-Ackerley
- Marina Marin
- Maud Mavigner
- Greg Melikian
- Manish Sharma
- Brian Zanoni
Respiratory Pathogens & Pandemic Preparedness Program
The Respiratory Pathogens Program comprises research related to RSV, SARS-CoV-2, Mycobacterium tuberculosis, and other pathogens causing illness in children. Hospital-level and global pandemic preparedness is also a a focus. Research leaders in this area include:
- Larry Anderson
- Ann Chahroudi
- Lisa Cranmer
- Marina Marin
- Maud Mavigner
- Greg Melikian
- Christina Rostad
- Andi Shane
- Manish Sharma
- Mehul Suthar
- Jens Wrammert
Antimicrobial Resistance and Stewardship Program
The development of sustainable programs to prevent and respond to increasing levels of resistance in bacterial pathogens is the focus of the Antimicrobial Resistance & Stewardship Program. Research leaders in this area include:
Clinical Trials Program
The Clinical Trials Program centers on the evaulation of vaccines, antimicrobials, and other interventions to prevent or treat infectious diseases in children and adolescents. Research leaders in this area include:
For more information on research from Emory University's Department of Pediatrics' Infectous Diseases Division, in which many CCIV researchers are housed, please click here.